Dr. Alexandre Chan, Founding Chair of the Department of Clinical Pharmacy Practice in the UC Irvine School of Pharmacy & Pharmaceutical Sciences, has been selected by the Hematology/Oncology Pharmacy Association (HOPA) as the recipient of their Basic and Clinical Research Literature Award!
He was recognized for the research that was presented in the article “Substance Use Among Young Adult Survivors of Childhood Cancer With Cognitive Impairment: An Analysis of the Project Forward Cohort.” The research was a collaborative study with Dr. Joel Milam of the Program in Public Health and student pharmacist Ding Quan (Quinton) Ng, as well as Anamara Ritt-Olson, David R. Freyer, Kimberly A. Miller, and Stefanie M. Thomas.
This study analyzes the relationship between cancer-related cognitive impairment (CRCI), psychological distress, and substance use behaviors (particularly vaping) among cancer survivors between the ages of 15 and 39. The results of the study showcase the significant mental challenges (both cognitive and emotional) that young adult cancer survivors face, likely causing these survivors to turn to tobacco, alcohol, and drugs.
The research for which he is being rewarded is in line with much of Dr. Chan’s work. He has dedicated significant research to furthering the understanding of CRCI, especially among young adult cancer survivors.
“I am very honored to receive this award on behalf of the research team,” he said. “This award will increase the awareness of post-cancer treatment related complications among young adult cancer patients. Currently, there is a lack of effective management strategies for cancer-related cognitive impairment among young adult cancer survivors, and my research group is addressing such unmet needs.”
This year’s awards were presented at the 2024 HOPA Annual Conference. Congratulations to Dr. Chan and all the honorees!
